Hepatocellular carcinoma(HCC)is one of the common malignant tumors of the digestive system,characterized by insidious onset,high malignancy,and poor prognosis.Early diagnosis and accurate evaluation of HCC can effectively guide clinical treatment,so as to improve the patients'overall clinical prognosis.Circulating tumor cell(CTC)testing is an important part of the liquid biopsy technology.CTC detection is a simple and accurate method,and can replace biopsy in diagnosing HCC partly.At the same time,CTC detection has also shown important application value in the clinical prognosis assessment of HCC patients,especially in the evaluation of postoperative recurrence of surgical patients.With the continuous development of CTC detection technology,its value in the clinical diagnosis and treatment of HCC will be further expanded,so that more HCC patients can benefit from it.
维普
万方数据